News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Daily News SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients Michael O'Riordan December 04, 2018
News Features Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe Todd Neale November 30, 2018
News Daily News PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study Michael O'Riordan November 23, 2018
News Daily News Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events L.A. McKeown November 21, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia Michael O'Riordan November 11, 2018
News Conference News AHA 2018 Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients Caitlin E. Cox November 11, 2018
News Conference News AHA 2018 Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI Todd Neale November 11, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Daily News Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors L.A. McKeown October 30, 2018
News Daily News Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60% Michael O'Riordan October 25, 2018
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Daily News Gender Gap May Be Narrowing in ACS Patients, With Mortality Advantage for Elderly Women L.A. McKeown October 12, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018